tetano
Editor, Senior Moderator
J Infect Dev Ctries. 2014 Oct 15;8(10):1301-6. doi: 10.3855/jidc.3890.
CXCL14 deficiency does not impact the outcome of influenza or Escherichia coli infections in mice.
Sidahmed AM1, Leon AJ, Banner D, Kelvin AA, Rowe T, Boudakov I, Degousse N, Rubin BB, Kelvin DJ.
Author information
Abstract
INTRODUCTION:
Chemokines are small proteins that regulate different cellular functions, such as leukocyte activation, chemoattraction and inflammation. The chemokine CXCL14 (BRAK) is a highly conserved gene among species and through evolution. It has been shown that CXCL14 is locally upregulated during viral infections, also, it has been found that this chemokine possesses direct antibacterial activities. Nonetheless, the exact role that CXCL14 plays during infection remains elusive.
METHODOLOGY:
CXCL14 deficient mice were generated in a C57B6/129 background and followed by phenotypic characterization. Later, the effect of CXCL14 deficiency during influenza infection and E. coli challenge was assessed.
RESULTS:
Other than a slight weight reduction, CXCL14 deficient mice exhibited no phenotypic alterations. CXCL14 deficiency did not influence the outcome of influenza virus infection or challenge with E. coli, and no statistically significant differences in clinical signs, cellular responses and histopathological findings were observed.
CONCLUSIONS:
CXCL14 does not seem to play a pivotal role during influenza and E. coli infections of the lung; these results are suggestive of functional overlap between CXCL14 and other chemokines that are present during lung infection.
PMID:
25313607
[PubMed - in process]
Free full text
http://www.ncbi.nlm.nih.gov/pubmed/25313607
CXCL14 deficiency does not impact the outcome of influenza or Escherichia coli infections in mice.
Sidahmed AM1, Leon AJ, Banner D, Kelvin AA, Rowe T, Boudakov I, Degousse N, Rubin BB, Kelvin DJ.
Author information
Abstract
INTRODUCTION:
Chemokines are small proteins that regulate different cellular functions, such as leukocyte activation, chemoattraction and inflammation. The chemokine CXCL14 (BRAK) is a highly conserved gene among species and through evolution. It has been shown that CXCL14 is locally upregulated during viral infections, also, it has been found that this chemokine possesses direct antibacterial activities. Nonetheless, the exact role that CXCL14 plays during infection remains elusive.
METHODOLOGY:
CXCL14 deficient mice were generated in a C57B6/129 background and followed by phenotypic characterization. Later, the effect of CXCL14 deficiency during influenza infection and E. coli challenge was assessed.
RESULTS:
Other than a slight weight reduction, CXCL14 deficient mice exhibited no phenotypic alterations. CXCL14 deficiency did not influence the outcome of influenza virus infection or challenge with E. coli, and no statistically significant differences in clinical signs, cellular responses and histopathological findings were observed.
CONCLUSIONS:
CXCL14 does not seem to play a pivotal role during influenza and E. coli infections of the lung; these results are suggestive of functional overlap between CXCL14 and other chemokines that are present during lung infection.
PMID:
25313607
[PubMed - in process]
Free full text
http://www.ncbi.nlm.nih.gov/pubmed/25313607